InvestorsHub Logo
Followers 5
Posts 351
Boards Moderated 0
Alias Born 12/18/2014

Re: None

Monday, 04/06/2015 8:53:44 AM

Monday, April 06, 2015 8:53:44 AM

Post# of 3108
NBS has 6 new events for April!>>>
NeoStem to Present at Multiple April Conferences



New York, April 6, 2015 - NeoStem, Inc. (NASDAQ:NBS) ("NeoStem" or the "Company"), a biopharmaceutical company developing novel cell-based personalized medicine therapies, announced today that the Company's management and experts will present at multiple conference in April.



HemOnc Today Melanoma and Cutaneous Malignancies
•Date and Time: Friday, April 10, 2015, 5:10 PM ET
•Venue: Sheraton New York Times Square Hotel, New York, New York
•Website: www.healio.com/meeting/hemonctodaymelanoma/home
•Presenter: Dr. Robert O. Dillman, Vice President, Oncology
•Poster: INTUS: Randomized Phase III Trial of Patient-specific Therapeutic Vaccine (NBS20) in Patients With Metastatic Melanoma

Crain's 'Business Of' Series: Life Sciences
•Date and Time: Wednesday, April 15, 2015, 8:30 AM - 10:00 AM ET
•Venue:John Jay College of Criminal Justice, New York, New York
•Website:http://www.crainsnewyork.com/events.../details/4/3256496
•Panelist: Dr. Robin L. Smith, Executive Chairman
•Topic:Life Sciences, Economic Diversification and Job Growth

Needham & Company's 14th Annual Healthcare Conference
•Date and Time: Wednesday, April 15, 2015, 3:00 PM ET
•Venue: The Westin Grand Central Hotel, New York, New York
•Website: ://www.needhamco.com/.../InstitutionalSa.../Conferences.aspx
•Presenter: Dr. David Mazzo, Chief Executive Officer
•Topic: Company Presentation
•Webcast:www.neostem.com/investors/investor-events/

American Association for Cancer Research Annual Meeting
•Date and Time: Wednesday, April 22, 2015, 8:00 AM ET
•Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania
•Website: www.aacr.org/Meetings/Pages/MeetingDetail.aspx...
•Presenter: Dr. Andrew N. Cornforth, Manufacturing Director
•Poster: Microarray analysis of melanoma autologous tumor cell lines used as the source of tumor associated antigens in patient-specific dendritic cell immunotherapy phase II trial in patients with metastatic melanoma

Interphex
•Date and Time: Wednesday, April 22, 2015, 2:00 PM ET
•Venue: Jacob Javits Center, New York, New York
•Website: www.interphex.com
•Presenter: Dr. Robert Preti, Chief Scientific Officer
•Topic: Development by Design: A Strategy to Support Commercial Success

Stem Cell Summit 2015
•Date and Time: Tuesday, April 28, 2015, 4:05 PM ET
•Venue: Hyatt Regency, Boston, Massachusetts
•Website: www.gtcbio.com/conferences/stem-cell-summit-agenda
•Presenter: Dr. Hans Keirstead, President, NeoStem Oncology
•Topic: Immunotherapy - Revolution in Cancer














Home - HemOnc Today Melanoma CME Meeting


You're invited to join more than 250 colleagues and...


healio.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News